We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+36.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.01B
AUM Growth
+$583M
Cap. Flow
-$32.3M
Cap. Flow %
-1.07%
Top 10 Hldgs %
19.61%
Holding
374
New
40
Increased
94
Reduced
116
Closed
88

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$26.9M
2
EBC icon
Eastern Bankshares
EBC
+$24.9M
3
MAX icon
MediaAlpha
MAX
+$21.2M
4
HLI icon
Houlihan Lokey
HLI
+$19.7M
5
ALGM icon
Allegro MicroSystems
ALGM
+$18.9M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$43.8M
2
BLD
TopBuild
BLD
+$38.3M
3
TWST icon
Twist Bioscience
TWST
+$28.8M
4
QTS
QTS REALTY TRUST, INC.
QTS
+$25M
5
PS
Pluralsight, Inc. Class A Common Stock
PS
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 23.28%
2 Technology 20.52%
3 Consumer Discretionary 15.17%
4 Industrials 13.7%
5 Financials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDOT icon
101
Green Dot
GDOT
$758M
$11.2M 0.37%
200,655
+21,502
+12% +$1.22M
FORM icon
102
FormFactor
FORM
$8.21B
$10.9M 0.36%
+254,518
New +$9.19M
LOB icon
103
Live Oak Bancshares
LOB
$1.93B
$10.3M 0.34%
+217,252
New +$8.71M
AMWL icon
104
American Well
AMWL
$210M
$10.2M 0.34%
20,081
+9,748
+94% +$5.64M
SMCI icon
105
Super Micro Computer
SMCI
$15.4B
$9.26M 0.31%
2,924,270
+1,045,610
+56% +$2.95M
JAMF
106
DELISTED
Jamf
JAMF
$9.07M 0.3%
303,038
+158,995
+110% +$5.24M
CERT icon
107
Certara
CERT
$1.08B
$8.78M 0.29%
+260,230
New +$9.53M
PASG icon
108
Passage Bio
PASG
$15.5M
$8.71M 0.29%
17,035
-46
-0.3% -$18.4K
NDLS icon
109
Noodles & Co
NDLS
$64M
$8.28M 0.27%
130,971
+88
+0.1% +$5.43K
SPNE
110
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$8.17M 0.27%
468,008
+133,765
+40% +$2.04M
FARO
111
DELISTED
Faro Technologies
FARO
$7.98M 0.26%
112,970
+53,757
+91% +$3.55M
CCNE icon
112
CNB Financial Corp
CCNE
$1.01B
$7.7M 0.26%
361,535
-1,523
-0.4% -$29.3K
OCFC icon
113
OceanFirst Financial
OCFC
$1.72B
$7.55M 0.25%
405,230
-199,166
-33% -$3.26M
MMSI icon
114
Merit Medical Systems
MMSI
$4.48B
$7.15M 0.24%
+128,777
New +$6.65M
BHVN
115
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$7M 0.23%
81,616
-116,836
-59% -$9.9M
AAPL icon
116
Apple
AAPL
$4.8T
$6.41M 0.21%
48,271
+220
+0.5% +$26.5K
TLYS icon
117
Tilly's
TLYS
$118M
$5.89M 0.2%
721,899
-1,360
-0.2% -$10.3K
OYST
118
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$5.49M 0.18%
291,936
-57,980
-17% -$1.25M
PRTS icon
119
CarParts.com
PRTS
$40.3M
$5.34M 0.18%
43,080
-2,723
-6% -$351K
MSFT icon
120
Microsoft
MSFT
$2.99T
$5.25M 0.17%
23,589
+895
+4% +$192K
AMZN icon
121
Amazon
AMZN
$2.69T
$4.22M 0.14%
25,920
-540
-2% -$86.2K
HYFM icon
122
Hydrofarm Holdings
HYFM
$3.24M
$4M 0.13%
+7,606
New +$3.98M
TRHC
123
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3.94M 0.13%
92,028
-132,902
-59% -$5.04M
CRDF icon
124
Cardiff Oncology
CRDF
$65.1M
$3.86M 0.13%
214,376
-144,959
-40% -$2.55M
HZNP
125
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.67M 0.12%
50,124
-589,441
-92% -$43.8M
3 4
5
6 7

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Emerald Advisers held 374 positions worth $3.01B, up 24% from $2.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Emerald Advisers's Q4 2020 filing shows 40 new, 94 increased, 116 reduced and 88 closed positions. Its largest new stake was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $43.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2020 buy was Ultragenyx Pharmaceutical: 226,875 shares worth $31.4M.
  • Emerald Advisers added most to Arena Pharmaceuticals Inc in Q4 2020, an estimated $18.6M increase.
  • Emerald Advisers's biggest Q4 2020 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $43.8M.
  • Emerald Advisers fully exited Pluralsight, Inc. Class A Common Stock in Q4 2020, selling an estimated $24.1M.
  • Emerald Advisers's ten largest holdings make up 20% of its $3.01B portfolio in Q4 2020.
  • Emerald Advisers opened 40 new positions and closed 88 in Q4 2020.
  • Emerald Advisers's portfolio value rose 24% quarter-over-quarter to $3.01B.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.